{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:38:20Z","timestamp":1783355900131,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41401-026-01753-5","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:20:05Z","timestamp":1770819605000},"page":"1605-1616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Triptolide derivative STP1 ameliorates murine systemic lupus erythematosus via targeting Fyn kinase"],"prefix":"10.1038","volume":"47","author":[{"given":"Qiao-yi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-zi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-da","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-tai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"1753_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","journal-title":"Nat Rev Dis Primers"},{"key":"1753_CR2","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1016\/j.apsb.2024.08.016","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang M, Chen HK, Zhang T, Zhang ZK, Xiang XW, Gao M, et al. Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus. Acta Pharmacol Sin B. 2024;14:4899\u2013913.","journal-title":"Acta Pharmacol Sin B"},{"key":"1753_CR3","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1016\/j.apsb.2024.09.008","volume":"14","author":"YF Feng","year":"2024","unstructured":"Feng YF, Chen CJ, Shao AQ, Wu L, Hu HY, Zhang TT. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharmacol Sin B. 2024;14:5091\u2013105.","journal-title":"Acta Pharmacol Sin B"},{"key":"1753_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/08916934.2019.1700232","volume":"53","author":"Y Feng","year":"2020","unstructured":"Feng Y, Yang M, Wu HJ, Lu QJ. The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical. Autoimmunity. 2020;53:56\u201364.","journal-title":"Autoimmunity"},{"key":"1753_CR5","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/s41401-025-01554-2","volume":"46","author":"YN Liang","year":"2025","unstructured":"Liang YN, Chen L, Huang QY, Song YT, Fan YJ, Chen TQ, et al. Immune cells in systemic lupus erythematosus: biology and traditional Chinese medicine therapy. Acta Pharmacol Sin. 2025;46:2587\u201396.","journal-title":"Acta Pharmacol Sin"},{"key":"1753_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ebiom.2019.06.038","volume":"45","author":"CQ Wang","year":"2019","unstructured":"Wang CQ, Ming BX, Wu XF, Wu T, Cai SZ, Hu P, et al. Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response. Ebiomedicine. 2019;45:578\u201387.","journal-title":"Ebiomedicine"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/eji.1830251040","volume":"25","author":"NJ Chalupny","year":"1995","unstructured":"Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, et al. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B-cell surface glycoprotein CD19 through their Src homology-2 domains. Eur J Immunol. 1995;25:2978\u201384.","journal-title":"Eur J Immunol"},{"key":"1753_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00294-0","volume":"8","author":"SB Mkaddem","year":"2017","unstructured":"Mkaddem SB, Murua A, Flament H, Titeca-Beauport D, Bounaix C, Danelli L, et al. Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat Commun. 2017;8:246.","journal-title":"Nat Commun"},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1753425916632305","volume":"3","author":"N Sharma","year":"2016","unstructured":"Sharma N, Akhade AS, Qadri A. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells. Innate Immun. 2016;3:238\u201344.","journal-title":"Innate Immun"},{"key":"1753_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14830","volume":"8","author":"S Dallari","year":"2017","unstructured":"Dallari S, Macal M, Loureiro ME, Jo Y, Swanson L, Hesser C, et al. Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses. Nat Commun. 2017;8:14380.","journal-title":"Nat Commun"},{"key":"1753_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1034\/j.1600-065X.2003.00015.x","volume":"191:","author":"R Zamoyska","year":"2003","unstructured":"Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol Rev. 2003;191:107\u201318.","journal-title":"Immunol Rev"},{"key":"1753_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10753-020-01355-1","volume":"44","author":"XZ Zhang","year":"2021","unstructured":"Zhang XZ, Mei D, Zhang LL, Wei W. Src family protein kinase controls the fate of B cells in autoimmune diseases. Inflammation. 2021;44:423\u201333.","journal-title":"Inflammation"},{"key":"1753_CR13","first-page":"132","volume":"36","author":"W Ji","year":"2022","unstructured":"Ji W, Lu YY, Ma ZY, Gan K, Liu Y, Cheng Y, et al. Triptolide attenuates inhibition of ankylosing spondylitis-derived mesenchymal stem cells on the osteoclastogenesis through modulating exosomal transfer of circ-0110634. J Orthop Transl. 2022;36:132\u201344.","journal-title":"J Orthop Transl"},{"key":"1753_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s42358-023-00311-5","volume":"63","author":"X Zhao","year":"2023","unstructured":"Zhao X, Ji W, Lu Y, Liu WW, Guo F. Triptolide regulates the balance of Tfr\/Tfh in lupus mice. Adv Rheumatol. 2023;63:29.","journal-title":"Adv Rheumatol"},{"key":"1753_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108010","volume":"99","author":"X Piao","year":"2021","unstructured":"Piao X, Zhou J, Xue L. Triptolide decreases rheumatoid arthritis fibroblast-like synoviocyte proliferation, invasion, inflammation and presents a therapeutic effect in collagen-induced arthritis rats via inactivating lncRNA RP11-83J16.1 mediated URI1 and \u03b2-catenin signaling. Int Immunopharmacol. 2021;99:108010.","journal-title":"Int Immunopharmacol"},{"key":"1753_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","volume":"90","author":"C Xi","year":"2017","unstructured":"Xi C, Peng SJ, Wu ZP, Zhou QP, Zhou J. Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother. 2017;90:531\u201341.","journal-title":"Biomed Pharmacother"},{"key":"1753_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2012.05.004","volume":"324","author":"L Wang","year":"2012","unstructured":"Wang L, Xu YP, Fu L, Li YC, Lou LG. (5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition. Cancer Lett. 2012;324:75\u201382.","journal-title":"Cancer Lett"},{"key":"1753_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2487-7","volume":"16","author":"TA Reno","year":"2016","unstructured":"Reno TA, Tong SW, Wu J, Fidler JM, Nelson R, Kim JY, et al. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer. BMC Cancer. 2016;16:439.","journal-title":"BMC Cancer"},{"key":"1753_CR19","first-page":"855","volume":"2","author":"JM Fidler","year":"2003","unstructured":"Fidler JM, Li K, Chung C, Wei K, Ross JA, Gao MX, et al. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol Cancer Ther. 2003;2:855\u201362.","journal-title":"Mol Cancer Ther"},{"key":"1753_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice. Arthritis Rheumatol. 2014;66:694\u2013706.","journal-title":"Arthritis Rheumatol"},{"key":"1753_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117342","volume":"287","author":"XY Chen","year":"2025","unstructured":"Chen XY, Guan JC, Lin YZ, Luo HW, Liu JY, Ma J, et al. Design and synthesis of novel sulfur-substituted triptolide with the ability to induce autophagy through inhibition of SRSF1 expression. Eur J Med Chem. 2025;287:117342.","journal-title":"Eur J Med Chem"},{"key":"1753_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704526","volume":"12","author":"J Lee","year":"2021","unstructured":"Lee J, Park Y, Jang SG, Hong SM, Song YS, Kim MJ, et al. Baricitinib attenuates autoimmune phenotype and podocyte injury in a murine model of systemic lupus erythematosus. Front Immunol. 2021;12:704526.","journal-title":"Front Immunol"},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1021\/acschembio.2c00099","volume":"17:","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li MR, Shen T, Yang TM, Shi GN, Wei YZ, et al. Celastrol targets cullin-associated and neddylation-dissociated 1 to prevent fibroblast-myofibroblast transformation against pulmonary fibrosis. ACS Chem Biol. 2022;17:2734\u201343.","journal-title":"ACS Chem Biol"},{"key":"1753_CR24","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1681\/ASN.2006101162","volume":"18","author":"RD Pawar","year":"2007","unstructured":"Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol. 2007;18:1721\u201331.","journal-title":"J Am Soc Nephrol"},{"key":"1753_CR25","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.4049\/jimmunol.178.12.7779","volume":"178:","author":"L Genestier","year":"2007","unstructured":"Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol. 2007;178:7779\u201386.","journal-title":"J Immunol"},{"key":"1753_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","volume":"192","author":"D Breitfeld","year":"2000","unstructured":"Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192:1545\u201351.","journal-title":"J Exp Med"},{"key":"1753_CR27","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.4049\/jimmunol.1302617","volume":"192","author":"JS Weinstein","year":"2014","unstructured":"Weinstein JS, Bertino SA, Hernandez SG, Poholek AC, Teplitzky TB, Nowyhed HN, et al. B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen. J Immunol. 2014;192:3166\u201379.","journal-title":"J Immunol"},{"key":"1753_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","volume":"1","author":"T Kawabe","year":"1994","unstructured":"Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, et al. The immune-responses in CD40-deficient mice - impaired immunoglobulin class switching and germinal center formation. Immunity. 1994;1:167\u201378.","journal-title":"Immunity"},{"key":"1753_CR29","doi-asserted-by":"publisher","first-page":"e60640","DOI":"10.1371\/journal.pone.0060640","volume":"8","author":"NS Chaimowitz","year":"2013","unstructured":"Chaimowitz NS, Falanga YT, Ryan JJ, Conrad DH. Fyn kinase is required for optimal humoral responses. PLoS One. 2013;8:e60640.","journal-title":"PLoS One"},{"key":"1753_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molonc.2009.01.002","volume":"3","author":"TP Green","year":"2009","unstructured":"Green TP, Fennell M, Whittaker R, Curwen J, Jacobs V, Allen J, et al. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol Oncol. 2009;3:248\u201361.","journal-title":"Mol Oncol"},{"key":"1753_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","volume":"83","author":"HB Nygaard","year":"2018","unstructured":"Nygaard HB. Targeting Fyn kinase in alzheimer\u2019s disease. Biol Psychiatry. 2018;83:369\u201376.","journal-title":"Biol Psychiatry"},{"key":"1753_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952775","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang FQ, Gao YN, Wang MJ, Gao Y, Li HC, et al. Triptolide in the treatment of systemic lupus erythematosus - regulatory effects on miR-146a in B cell TLR7 signaling pathway in mice. Front Pharmacol. 2022;13:952775.","journal-title":"Front Pharmacol"},{"key":"1753_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.intimp.2019.02.047","volume":"71","author":"X Zhao","year":"2019","unstructured":"Zhao X, Tang XJ, Yan Q, Song H, Li ZT, Wang DD, et al. Triptolide ameliorates lupus via the induction of miR-125a-5p-mediating Treg upregulation. Int Immunopharmacol. 2019;71:14\u201321.","journal-title":"Int Immunopharmacol"},{"key":"1753_CR34","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.intimp.2005.06.009","volume":"5","author":"R Zhou","year":"2005","unstructured":"Zhou R, Zhang F, He PL, Zhou WL, Wu QL, Xu JY, et al. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo. Int Immunopharmacol. 2005;5:1895\u2013903.","journal-title":"Int Immunopharmacol"},{"key":"1753_CR35","doi-asserted-by":"publisher","first-page":"156ra139","DOI":"10.1126\/scitranslmed.3004334","volume":"4","author":"R Chugh","year":"2012","unstructured":"Chugh R, Sangwan V, Patil SP, Dudeja V, Dawra RK, Banerjee S, et al. A preclinical evaluation of minnelide as a therapeutic agent against pancreatic cancer. Sci Transl Med. 2012;4:156ra139.","journal-title":"Sci Transl Med"},{"key":"1753_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110084","volume":"126","author":"JM Fu","year":"2020","unstructured":"Fu JM, Zang YD, Zhou Y, Chen CJ, Shao S, Hu M, et al. A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype. Biomed Pharmacother. 2020;126:110084.","journal-title":"Biomed Pharmacother"},{"key":"1753_CR37","doi-asserted-by":"publisher","first-page":"13340","DOI":"10.3390\/molecules181113340","volume":"18:","author":"C Zhang","year":"2013","unstructured":"Zhang C, Gu CH, Peng F, Liu W, Wan JL, Xu HB, et al. Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation. Molecules. 2013;18:13340\u201356.","journal-title":"Molecules"},{"key":"1753_CR38","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.2147\/IJN.S498099","volume":"19","author":"LL Zhou","year":"2024","unstructured":"Zhou LL, Du Y, Shang YT, Xiang DB, Xia XH. A novel triptolide nano-liposome with mitochondrial targeting for treatment of hepatocellular carcinoma. Int J Nanomed. 2024;19:12975\u201398.","journal-title":"Int J Nanomed"},{"key":"1753_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-021-00525-z","volume":"16","author":"YX Cheng","year":"2021","unstructured":"Cheng YX, Zhao YH, Zheng Y. Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity. Chin Med. 2021;16:114.","journal-title":"Chin Med"},{"key":"1753_CR40","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1016\/j.apsb.2024.06.024","volume":"10","author":"L Wang","year":"2024","unstructured":"Wang L, Yin HY, Jiang J, Li QL, Gao CX, Li WR, et al. A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus. Acta Pharmacol Sin B. 2024;10:4560\u201376.","journal-title":"Acta Pharmacol Sin B"},{"key":"1753_CR41","doi-asserted-by":"publisher","first-page":"13084","DOI":"10.3390\/ijms160613084","volume":"16","author":"KY Ma","year":"2015","unstructured":"Ma KY, Li JY, Fang YF, Lu LW. Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus. Int J Mol Sci. 2015;16:13084\u2013105.","journal-title":"Int J Mol Sci"},{"key":"1753_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.12821","volume":"292","author":"E Meffre","year":"2019","unstructured":"Meffre E, O\u2019Connor KC. Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies. Immunol Rev. 2019;292:90\u2013101.","journal-title":"Immunol Rev"},{"key":"1753_CR43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2017.01.050","volume":"18","author":"M Kuraoka","year":"2017","unstructured":"Kuraoka M, Snowden PB, Nojima T, Verkoczy L, Haynes BF, Kitamura D, et al. BCR and endosomal TLR signals synergize to increase AID expression and establish central B cell tolerance. Cell Rep. 2017;18:1627\u201335.","journal-title":"Cell Rep"},{"key":"1753_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","volume":"6","author":"LC Kim","year":"2009","unstructured":"Kim LC, Song LX, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 2009;6:587\u201395.","journal-title":"Nat Rev Clin Oncol"},{"key":"1753_CR45","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.4049\/jimmunol.181.8.5374","volume":"181:","author":"AA Mamchak","year":"2008","unstructured":"Mamchak AA, Sullivan BM, Hou BD, Lee LM, Gilden JK, Krummel MF, et al. Normal development and activation but altered cytokine production of Fyn-deficient CD4 T cells. J Immunol. 2008;181:5374\u201385.","journal-title":"J Immunol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01753-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:02:31Z","timestamp":1779440551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01753-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01753-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the fund number \u201cCAMS Innovation Fund for Medical Science of China (2025-I2M-XHXX-080)\u201d was incorrect.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}